Tandem Diabetes Care, Inc.
TNDM
$14.41
$0.070.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.54% | 7.93% | 17.87% | 25.84% | 27.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.54% | 7.93% | 17.87% | 25.84% | 27.65% |
| Cost of Revenue | -1.38% | 4.02% | 9.80% | 17.23% | 20.25% |
| Gross Profit | 9.95% | 11.53% | 26.00% | 34.79% | 35.28% |
| SG&A Expenses | 8.07% | 11.36% | 14.79% | 19.49% | 18.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.27% | 5.15% | 10.50% | 16.82% | 18.76% |
| Operating Income | 33.59% | 21.19% | 35.89% | 34.10% | 31.94% |
| Income Before Tax | 43.78% | -117.99% | -66.35% | -54.14% | -28.07% |
| Income Tax Expenses | -137.23% | 6.81% | -143.84% | -41.27% | 79.53% |
| Earnings from Continuing Operations | 48.58% | -113.18% | -60.41% | -50.52% | -29.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.58% | -113.18% | -60.41% | -50.52% | -29.98% |
| EBIT | 33.59% | 21.19% | 35.89% | 34.10% | 31.94% |
| EBITDA | 42.45% | 26.74% | 41.68% | 39.26% | 36.77% |
| EPS Basic | 49.66% | -108.59% | -57.02% | -47.67% | -28.22% |
| Normalized Basic EPS | 12.81% | -2.66% | 25.04% | 29.06% | 32.15% |
| EPS Diluted | 49.66% | -108.59% | -57.02% | -47.67% | -28.22% |
| Normalized Diluted EPS | 12.82% | -2.65% | 25.03% | 29.05% | 32.14% |
| Average Basic Shares Outstanding | 3.13% | 2.80% | 2.23% | 1.58% | 0.86% |
| Average Diluted Shares Outstanding | 3.05% | 2.71% | 2.31% | 1.67% | 0.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |